Document is current

Article History

Received: 5 September 2023

Accepted: 19 September 2023

First Online: 21 October 2023

Declarations

:

: Dr. Roy E. Strowd serves as a consultant for Monteris Medical and Novocure. He receives an editorial stipend from the American Academy of Neurology. He has received research/grant support from the American Academy of Neurology, American Society for Clinical Oncology, Southeastern Brain Tumor Foundation, Jazz Pharmaceuticals, and the International Association for Medical Science Educators. He receives royalties from Elsevier, Lecturio and Kaplan Medical. Dr. Benjamin Ellingson, Ms. Catalina Raymond, Dr. Jingwen Yao, Dr. Anna Piotrowski, Dr. Arati Desai, Dr. Frank Lieberman, Ms. Serena Desideri, Dr. Xiaobu Ye and Dr. Stuart Grossman has nothing to disclose. Dr. Patrick Wen has received research support from Astra Zeneca/Medimmune, Beigene, Celgene, Chimerix, Eli Lily, Genentech/Roche, Kazia, MediciNova, Merck, Novartis, Nuvation Bio, Puma, Servier, Vascular Biogenics, VBI Vaccines and serves on advisory boards for Astra Zeneca, Bayer, Black Diamond, Boehringer Ingelheim, Boston Pharmaceuticals, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Karyopharm, Merck, Mundipharma, Novartis, Novocure, Nuvation Bio, Prelude Therapeutics, Sapience, Servier, Sagimet, Vascular Biogenics, and VBI Vaccines. Dr. Manmeet Ahluwalia receives grants/research support from Astrazeneca, BMS, Bayer, Incyte, Pharmacyclics, Novocure, Mimivax, and Merck, consults for Bayer, Novocure, Kiyatec, Insightec, GSK, Xoft, Nuvation, Cellularity, SDP Oncology, Apollomics, Prelude, Janssen, Tocagen, Voyager Therapeutics, Viewray, Caris Lifesciences, Pyramid Biosciences, AnHeart Therapeutics, Varian Medical Systems, and Cairn Therapeutics, is on the Scientific Advisory Board for Cairn Therapeutics and Pyramid Biosciences, and is a stock shareholder for Mimivax, Cytodyn, MedInnovate Advisors LLC. Dr. Jennifer Clarke has served as consultant for Servier Pharmaceuticals and Agios Pharmaceuticals. Research support from Servier Pharmaceuticals, Agios Pharmaceuticals, and Merck & Co. Dr. L. Burt Nabros, MD serves on scientific advisory board for Chimerix and chairs the data safety monitoring committee for CNS Pharma. M.P. has consulted for Bayer, is a member of the HI-TRON Scientific Management Board and holds patents for peptides for use in treating or diagnosing IDH1R132H positive cancers (EP2800580B1).